[go: up one dir, main page]

MXPA03000905A - Compuestos de poliamina ciclicos como tratamiento contra el cancer. - Google Patents

Compuestos de poliamina ciclicos como tratamiento contra el cancer.

Info

Publication number
MXPA03000905A
MXPA03000905A MXPA03000905A MXPA03000905A MXPA03000905A MX PA03000905 A MXPA03000905 A MX PA03000905A MX PA03000905 A MXPA03000905 A MX PA03000905A MX PA03000905 A MXPA03000905 A MX PA03000905A MX PA03000905 A MXPA03000905 A MX PA03000905A
Authority
MX
Mexico
Prior art keywords
cancer therapy
polyamine compounds
cyclic polyamine
cyclic
compounds
Prior art date
Application number
MXPA03000905A
Other languages
English (en)
Inventor
Benjamin Frydman
Original Assignee
Slil Biomedical Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Slil Biomedical Corp filed Critical Slil Biomedical Corp
Publication of MXPA03000905A publication Critical patent/MXPA03000905A/es

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D255/00Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00
    • C07D255/02Heterocyclic compounds containing rings having three nitrogen atoms as the only ring hetero atoms, not provided for by groups C07D249/00 - C07D253/00 not condensed with other rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
MXPA03000905A 2000-08-02 2001-08-02 Compuestos de poliamina ciclicos como tratamiento contra el cancer. MXPA03000905A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US22252200P 2000-08-02 2000-08-02
PCT/US2001/024282 WO2002010142A1 (en) 2000-08-02 2001-08-02 Cyclic polyamine compounds for cancer therapy

Publications (1)

Publication Number Publication Date
MXPA03000905A true MXPA03000905A (es) 2003-06-24

Family

ID=22832553

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03000905A MXPA03000905A (es) 2000-08-02 2001-08-02 Compuestos de poliamina ciclicos como tratamiento contra el cancer.

Country Status (7)

Country Link
EP (1) EP1305299A1 (es)
JP (1) JP2004505112A (es)
AU (2) AU2001278143B2 (es)
CA (1) CA2417064A1 (es)
IL (1) IL153864A0 (es)
MX (1) MXPA03000905A (es)
WO (1) WO2002010142A1 (es)

Families Citing this family (40)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HK1040993B (en) 1999-04-30 2006-11-10 Cellgate, Inc. Polyamines and their use in therapy
EP1337504A4 (en) 2000-11-08 2005-10-05 Cellgate Inc NOVEL AMINO ACID CONJUGATES AND POLYAMINE ANALOGUES USEFUL AS ANTICANCING AGENTS
JP2005533820A (ja) * 2002-06-26 2005-11-10 セルゲイト, インコーポレイテッド 癌治療のためのポルフィリン−ポリアミン結合体
BRPI0614805A2 (pt) 2005-08-10 2011-04-12 Univ Johns Hopkins poliaminas úteis como produtos terapêuticos antiparasìticos e anticáncer e como inibidores de demetilase lisina-especìficos
US9241898B2 (en) 2008-03-11 2016-01-26 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
US9822364B2 (en) 2008-03-11 2017-11-21 Yale University Compositions and methods for controlled delivery of inhibitory ribonucleic acids
US9895451B2 (en) 2011-12-02 2018-02-20 Yale University Formulations for targeted release of agents to low pH tissue environments or cellular compartments and methods of use thereof
WO2013082529A1 (en) 2011-12-02 2013-06-06 Yale University Enzymatic synthesis of poly(amine-co-esters) and methods of use thereof for gene delivery
US10465042B2 (en) 2011-12-02 2019-11-05 Yale University Poly(amine-co-ester) nanoparticles and methods of use thereof
IN2012DE00661A (es) 2012-03-07 2015-08-21 Univ Delhi
DE112013002530T5 (de) * 2012-05-15 2015-02-19 Thermo Electron Scientific Instruments Llc Ultrabreitbandige mehrschichtige dielektrische Strahlteilerbeschichtung
US11918695B2 (en) 2014-05-09 2024-03-05 Yale University Topical formulation of hyperbranched polymer-coated particles
WO2015172149A1 (en) 2014-05-09 2015-11-12 Yale University Hyperbranched polyglycerol-coated particles and methods of making and using thereof
US10815276B2 (en) 2014-05-21 2020-10-27 Entrada Therapeutics, Inc. Cell penetrating peptides and methods of making and using thereof
HRP20191254T1 (hr) 2014-05-21 2019-10-18 Entrada Therapeutics, Inc. Peptidi koji prodiru u stanice i postupci za njihovu proizvodnju i uporabu
EP3185880B1 (en) 2014-08-27 2020-02-12 Ohio State Innovation Foundation Improved peptidyl calcineurin inhibitors
WO2016081621A1 (en) 2014-11-18 2016-05-26 Yale University Formulations for targeted release of agents under low ph conditions and methods of use thereof
US10682422B2 (en) 2014-11-18 2020-06-16 Yale University Formulations for targeted release of agents under low pH conditions and methods of use thereof
EP3416976A2 (en) 2016-02-16 2018-12-26 Yale University Compositions for enhancing targeted gene editing and methods of use thereof
WO2017143061A1 (en) 2016-02-16 2017-08-24 Yale University Compositions and methods for treatment of cystic fibrosis
WO2017197128A1 (en) 2016-05-11 2017-11-16 Yale University Poly(amine-co-ester) nanoparticles and methods of use thereof
US20200113821A1 (en) 2017-04-04 2020-04-16 Yale University Compositions and methods for in utero delivery
WO2019070962A1 (en) 2017-10-04 2019-04-11 Ohio State Innovation Foundation BICYCLIC PEPTIDE INHIBITORS
US11793884B2 (en) 2018-01-29 2023-10-24 Ohio State Innovation Foundation Cyclic peptidyl inhibitors of CAL-PDZ binding domain
WO2019148194A2 (en) 2018-01-29 2019-08-01 Ohio State Innovation Foundation Peptidyl inhibitors of calcineurin-nfat interaction
WO2019165183A1 (en) 2018-02-22 2019-08-29 Entrada Therapeutics, Inc. Compositions and methods for treating mitochondrial neurogastrointestinal encephalopathy
EP3790890A4 (en) 2018-05-09 2022-03-02 Ohio State Innovation Foundation CYCLIC PEPTIDES OF CELL PENETRATION WITH ONE OR MORE HYDROPHOBIC RESIDUES
WO2020033951A1 (en) 2018-08-10 2020-02-13 Yale University Compositions and methods for embryonic gene editing in vitro
US11814464B2 (en) 2019-04-29 2023-11-14 Yale University Poly(amine-co-ester) polymers and polyplexes with modified end groups and methods of use thereof
WO2020257776A1 (en) 2019-06-21 2020-12-24 Yale University Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
US20220372474A1 (en) 2019-06-21 2022-11-24 Yale University Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
WO2021022161A1 (en) 2019-07-31 2021-02-04 Yale University Compositions and methods for treating sickle cell disease
US12428658B2 (en) 2019-11-25 2025-09-30 The General Hospital Corporation Methods and compositions for enzymatic polymerization of N3′→P5′ phosphoramidate DNA
CA3183351A1 (en) 2020-06-19 2021-12-23 Yale University Poly(amine-co-ester) polymers with modified end groups and enhanced pulmonary delivery
US20220031633A1 (en) 2020-07-28 2022-02-03 Yale University Poly(amine-co-ester) polymeric particles for selective pulmonary delivery
CA3240179A1 (en) 2021-12-08 2023-06-15 Alexandra Piotrowski-Daspit Surface conjugation to poly(amine-co-ester) nanoparticles for targeting to cells and tissues
WO2023159189A1 (en) 2022-02-18 2023-08-24 Yale University Branched poly(amine-co-ester) polymers for more efficient nucleic expression
GB202307563D0 (en) 2023-05-19 2023-07-05 Univ King Abdullah Sci & Tech Methods and compositions
US20250032644A1 (en) 2023-07-25 2025-01-30 Massachusetts Institute Of Technology Compositions and methods for treating fan1 associated trinucleotide repeat expansion disorders
CN117088825A (zh) * 2023-10-12 2023-11-21 成都威斯津生物医药科技有限公司 一种可离子化脂质、含该可离子化脂质的药物组合物及其用途

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4999349A (en) * 1990-03-22 1991-03-12 Bristol-Myers Squibb Co. BU-4164E - A and B, prolyl endopeptidase inhibitors
DE69704731D1 (de) * 1996-02-27 2001-06-13 Lilly Co Eli Cryptophycinderivate und ihre Verwendung als antimikrotubuli Mittel

Also Published As

Publication number Publication date
WO2002010142A1 (en) 2002-02-07
CA2417064A1 (en) 2002-02-07
IL153864A0 (en) 2003-07-31
AU2001278143B2 (en) 2007-08-09
JP2004505112A (ja) 2004-02-19
AU7814301A (en) 2002-02-13
EP1305299A1 (en) 2003-05-02

Similar Documents

Publication Publication Date Title
MXPA03000905A (es) Compuestos de poliamina ciclicos como tratamiento contra el cancer.
DE60223699D1 (en) Diarylsulfidderivat, dessen additionssalz und immunsuppressivum
MXPA03001419A (es) Combinacion terapeutica de un inhibidor de la proteina de transferencia de esteres de colesterol y atorvastatina.
AU2001282717A1 (en) Cancer treatment by combination therapy
EP1463438A4 (en) ENDOMURAL THERAPY
GB0028429D0 (en) Therapy
ZA200410015B (en) Pharmaceutical salts.
GB0008710D0 (en) Therapeutic compounds
AU2002226650A8 (en) Redox therapy for tumors
GB0016681D0 (en) Therapeutic compounds
MXPA03006250A (es) Compuestos heterociclicos terapeuticos.
MXPA03006268A (es) Compuestos terapeuticos de cromano.
MXPA03006261A (es) Compuestos terapeuticos de cromano.
GB2367993B (en) Radiotherapy apparatus
GB0101933D0 (en) Therapy
GB0026015D0 (en) Cancer treatment
HK1055434A (en) Cyclic polyamine compounds for cancer therapy
EP1463511A4 (en) COMBINATORY ANTICANCER THERAPY
GB0013105D0 (en) Therapeutic compounds
ZA200306403B (en) Cancer treatment.
ZA200304439B (en) Therapeutic treatment.
IT1316431B1 (it) Apparecchio per auricolo terapia.
GB0015215D0 (en) Tumour therapy
GB0029577D0 (en) Therapy
GB0020942D0 (en) Therapy

Legal Events

Date Code Title Description
FA Abandonment or withdrawal